New Japan Chemical Co., Ltd. (TYO:4406)
Japan · Delayed Price · Currency is JPY 254.00
-1.00 (-0.39%)
Aug 27, 2026, 3:25 PM JST
New Japan Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 33,366 | 32,105 | 32,703 | 32,863 | 33,105 | 32,358 | |
Revenue Growth | 2.22% | -1.83% | -0.49% | -0.73% | 2.31% | 32.41% |
Cost of Revenue | 27,328 | 26,779 | 27,249 | 27,547 | 28,687 | 26,473 |
Gross Profit | 6,038 | 5,326 | 5,454 | 5,316 | 4,418 | 5,885 |
Selling, General & Admin | 3,807 | 3,830 | 3,678 | 4,106 | 3,979 | 3,858 |
Research & Development | 919 | 919 | 946 | 848 | 878 | 824 |
Operating Expenses | 4,726 | 4,749 | 4,624 | 4,954 | 4,857 | 4,682 |
Operating Income | 1,312 | 577 | 830 | 362 | -439 | 1,203 |
Interest Expense | -76 | -69 | -50 | -47 | -51 | -44 |
Interest & Investment Income | 200 | 197 | 175 | 177 | 170 | 147 |
Earnings From Equity Investments | 58 | -9 | 392 | 228 | 401 | 179 |
Currency Exchange Gain (Loss) | -6 | 3 | -26 | -2 | -21 | - |
Other Non Operating Income (Expenses) | -70 | -124 | -109 | 66 | 62 | 103 |
EBT Excluding Unusual Items | 1,418 | 575 | 1,212 | 784 | 122 | 1,588 |
Gain (Loss) on Sale of Investments | 615 | 636 | 271 | 221 | -3 | -132 |
Gain (Loss) on Sale of Assets | -30 | -30 | -16 | -5 | -17 | - |
Asset Writedown | - | - | - | -253 | -332 | -526 |
Other Unusual Items | -504 | -504 | -744 | -229 | -1 | -1 |
Pretax Income | 1,499 | 677 | 723 | 518 | -231 | 929 |
Income Tax Expense | 77 | 32 | 155 | 182 | 166 | 49 |
Earnings From Continuing Operations | 1,422 | 645 | 568 | 336 | -397 | 880 |
Minority Interest in Earnings | -59 | -48 | -46 | -116 | -47 | -69 |
Net Income | 1,363 | 597 | 522 | 220 | -444 | 811 |
Net Income to Common | 1,363 | 597 | 522 | 220 | -444 | 811 |
Net Income Growth | 149.18% | 14.37% | 137.27% | - | - | 61.88% |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Change | - | - | -0.00% | -0.00% | - | -0.00% |
EPS (Basic) | 36.56 | 16.01 | 14.00 | 5.90 | -11.91 | 21.75 |
EPS (Diluted) | 36.56 | 16.01 | 14.00 | 5.90 | -11.91 | 21.75 |
EPS Growth | 149.18% | 14.37% | 137.28% | - | - | 61.88% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,321 | -889 | 2,799 | -589 | -705 |
Free Cash Flow Per Share | - | 35.43 | -23.84 | 75.07 | -15.80 | -18.91 |
Dividend Per Share | 4.500 | 4.500 | 4.000 | - | - | 5.000 |
Dividend Growth | 12.50% | 12.50% | - | - | - | 66.67% |
Gross Margin | 18.10% | 16.59% | 16.68% | 16.18% | 13.35% | 18.19% |
Operating Margin | 3.93% | 1.80% | 2.54% | 1.10% | -1.33% | 3.72% |
Profit Margin | 4.08% | 1.86% | 1.60% | 0.67% | -1.34% | 2.51% |
Free Cash Flow Margin | - | 4.12% | -2.72% | 8.52% | -1.78% | -2.18% |
EBITDA | 2,059 | 1,332 | 1,618 | 1,104 | 271 | 1,969 |
EBITDA Margin | 6.17% | 4.15% | 4.95% | 3.36% | 0.82% | 6.08% |
D&A For EBITDA | 746.75 | 755 | 788 | 742 | 710 | 766 |
EBIT | 1,312 | 577 | 830 | 362 | -439 | 1,203 |
EBIT Margin | 3.93% | 1.80% | 2.54% | 1.10% | -1.33% | 3.72% |
Effective Tax Rate | 5.14% | 4.73% | 21.44% | 35.13% | - | 5.27% |